Sanger researcher elected to U.S. National Academy Of Medicine
The Sanger Institute’s Dr Peter Campbell has been elected to the U.S National Academy of Medicine, in recognition of his contribution to the field of cancer genomics. Dr Campbell is Head of the Institute’s Cancer, Ageing and Somatic Mutation programme, having joined Sanger as a post-doctoral fellow in 2007.
Optibrium expands operations in North America for AI and computational drug discovery technologies
CAMBRIDGE, UK and CAMBRIDGE, US – Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, announces the opening of its US subsidiary, Optibrium Inc., and the promotion of Dr Tamsin Mansley to President of the new subsidiary to lead its US-based team and business operations.
Multimillion pound award for Biomedical Research Centre to translate research discoveries into new treatments for patients
The National Institute for Health and Care Research (NIHR) awards £86.2 million to NIHR Cambridge Biomedical Research Centre (BRC) investigators to continue their ground-breaking research, translating new scientific insights into state-of-the-art diagnostics and treatments to transform healthcare.
October update from Guardtech - aiming to end a prosperous year on a high
Suffolk-based cleanroom construction company ready for final push in remaining months of busiest ever year.
![Dr Mike Macnamee (left) and new CEO Dr Thanos Papathanasiou outside Bourn Hall Clinic, the world’s first IVF clinic [credit: Bourn Hall]](/sites/default/files/styles/article_card/public/Dr%20Mike%20Macnamee%20with%20new%20Bourn%20Hall%20CEO%20Dr%20Thanos%20Papathanasiou%20CamNet.JPG?itok=fAL9HkZP)
Dr Thanos Papathanasiou becomes CEO at world-renowned Bourn Hall IVF Clinic
Dr Thanos Papathanasiou, Medical Director at Bourn Hall, the world’s first IVF clinic, has been appointed its new CEO, succeeding Dr Mike Macnamee.
Best practices for measuring dew point in transmission gas
Protecting pipelines and gas power systems
Pure shortlisted for two Investors In People Awards
The Pure team are really pleased to announce that it has made the final shortlists for two awards at the Investors in People Awards 2022. With entries from over three hundred organisations – a record-breaking year – this is an amazing achievement.
Incident Response Plans - how to prepare for a cyber attack
Barnes Commercial Insurance Broker says - read our advice on how to form an effective incident response plan to protect your business and its data in the event of a cyber attack.
Mission Street and BGO plot new Cambridge science district
Partners have purchased a 23 acre site for their lab space joint venture
Free spaces available on Evolve Workplace Wellbeing Network
Evolve Workplace Wellbeing have a number of free places available for the first group to join their new online Evolve Workplace Wellbeing network: a chance for like-minded managers, HR practitioners and business leaders to hear cutting-edge insight into workplace wellbeing (from our research) and
Biocair announces event to advise on building a resilient supply chain
Biocair is aiming to educate Contract Manufacturing Organisations (CMOs) and pharmaceutical sponsors on the value of lane risk assessments ahead of shipping Active Pharmaceutical Ingredients (APIs) and finished drug products globally.
New headline results from Phase I clinical trial of ultra-rapid acting insulin candidate AT247
Cambridge UK - Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces headline results from the second Phase I clinical trial of its ultra-rapid acting insulin, AT247, which support its potential to facilitate a fully closed loop artificial pancreas.
Sensors in Medicine 2022 - just 4 weeks away
The 10th Annual Sensors in Medicine 2022 conference takes place online from 8 - 11 November. Each session is held from 2:00pm to 6:00pm (GMT) daily. Technical sessions are on: Sweat analysis; Molecular sensors; Wearable sensors; Sensors for infectious diseases; the Future of Sensors.
Bittersweet Celebration at the Ex-Forces in Business Awards
John Dibb says - attending the Ex-Forces in Business Awards last month was an incredible celebration. The tributes to those with military careers and forging new ones was an honour to witness, and it was an even bigger honour to have been shortlisted myself for Entrepreneur of the Year.
CPFT clinician wins national award for mental health studies
CPFT psychiatrist Dr Emilio Fernandez-Egea has received a prestigious national research grant to learn more about schizophrenia and how best to treat this complex mental health condition.
New MRI scanner at Addenbrooke’s is UK first
Addenbrooke’s has become the first hospital in the UK to have a new advanced MRI scanner which uses artificial intelligence (AI) to improve image quality, reduce waiting times, and open new opportunities for research.
Introducing Projection Micro Stereolithography (PµSL)
Prototype Projects says - we're really excited to make a BIG announcement about a new 3D Printing process that makes teeny tiny parts which are incredibly accurate. Introducing... Projection Micro Stereolithography, or PµSL, an exciting additive manufacturing technology for building parts that cannot be produced using other technologies such as conventional SLA, DLP, SLS or PolyJet.
Creating the world’s largest longitudinal medical imaging dataset
Public-private partnership announces ambitious project to create the world’s largest longitudinal imaging dataset to assess disease progression.
Part 2: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part II of this article was originally published in PharmaPhorum.
Zetta Genomics appoints director to lead strategic partnerships
Andy Etheridge joins Zetta Genomics alongside a new Head of Product, tasked to power customer-focused solution development
Stephen Galt, formerly of Fishawack Health, joins Cambridge Healthcare Research as Chief Commercial Officer
Cambridge, England - Stephen Galt has been appointed as Chief Commercial Officer by the Board of Directors at Cambridge Healthcare Research (CHR) to support the business through its next period of growth.
Lab Hotel at Stevenage Bioscience Catalyst now fully booked
Stevenage Bioscience Catalyst (SBC) has awarded space in its Lab Hotel to start-ups Neobe Therapeutics and Genenet Technology. The Lab Hotel is a unique facility offering free lab and office accommodation for six months.
Optibrium strengthens global AI drug discovery software operations with three key appointments
Cambridge, UK - Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, announces three key appointments: Michelle Harrison as Head of Strategic Marketing, Chris Khoury as Associate Director of Business Development, and Imran Ghauri as Business Development Manager.
Part 1: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part I of this article was originally published in PharmaPhorum.
my mhealth announces appointment of David Pettigrew as their new CEO
CAMBRIDGE UK - my mhealth, a leading Digital Therapeutics (DTx) company based in the UK, is pleased to announce the promotion of Dr. David Pettigrew as CEO.